Abstract
(1) Background: There are no real-world data evaluating the incidence of false-positive results. We analyzed the clinical and analytical factors associated with the presence of false-positive results in PSA determinations in practice. (2) Methods: A prospective cohort study of patients with a PSA test was performed in clinical practice. We followed the patients by reviewing their medical records for 2 years or until the diagnosis of PCa was reached, whichever came first. (3) Results: False-positive PSA rate was 46.8% (95% CI 44.2–49.2%) and false-negative PSA rate was 2.8% (95% CI 2–3.5%). Patients aged 61–70 years and those over 70 years were more likely to have a false-positive result than those under 45 years (aOR 2.83, 95% CI 1.06–7.55, p = 0.038, and aOR 4.62, 95% CI 1.75–12.22, p = 0.002, respectively). Patients with urinary tract infection were more likely to have a false-positive result (aOR 8.42, 95% CI 2.42–29.34, p = 0.001). Patients with diabetes mellitus were less likely to have a false-positive result (aOR 0.63, 95% CI 0.41–0.98, p = 0.038); (4) Conclusions: This study has generated relevant information that could be very useful for shared decision making in clinical practice.
Funder
Institute of Health Carlos III
European Regional Development Fund
Reference36 articles.
1. Assessment of prostate-specific antigen screening: An evidence-based report by the German Institute for Quality and Efficiency in Health Care;Paschen;BJU Int.,2022
2. PSA screening—A matter of debate?;Heidegger;Memo,2019
3. Ilic, D., Neuberger, M.M., Djulbegovic, M., and Dahm, P. (2013). Screening for prostate cancer. Cochrane Database Syst. Rev., 1.
4. Age related prostate specific antigen reference range among men in south-east caspian sea;Mansourian;Pakistan J. Biol. Sci.,2007
5. Untangling the association between prostate-specific antigen and diabetes: A systematic review and meta-analysis;Lumbreras;Clin. Chem. Lab. Med.,2020
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献